510(k) Decision-Making Flowchart: FDA Process for Medical Devices
The 510(k) Decision-Making Flowchart (refer to flowchart below) is a critical tool in the regulatory pathway for medical devices in the United States. This flowchart guides manufacturers through the steps required for a 510(k) premarket submission to the U.S. Food and Drug Administration (FDA), helping them demonstrate that their device is at least as safe and effective, or substantially equivalent, to a legally marketed device that does not require premarket approval (PMA).
Elexes has guided numerous medical device manufacturers through the 510(k) pathway using our proprietary flowchart‑based on the submission planning. If you’re a Regulatory Affairs manager or device manufacturer preparing a U.S. market entry, this FDA 510(k) decision-making flowchart will guide your path and key decision points.
Here is an overview of the key steps in the 510(k) decision-making process:
The procedure of the 510(k) includes device classification, predicate determination, development of support documents, FDA filing, and review process. In addition, the decision-making process of the substantial equivalence at FDA involves the evaluation of the intention of use of the device and whether the difference in the technological features leads to different issues of safety and effectiveness. Below is the chart showing this process.
⦿ Device Classification:
Identify the classification (I, II, or III) of the device to be submitted for approval by FDA, considering its intended use and the applicable classification rule. There are devices which do not need to undergo 510(k) process and some of these are even exempted.
⦿ Preparation of the 510(k) Submission:
Compile and prepare a comprehensive 510(k) submission that includes detailed information about the device, its intended use, technological characteristics, and performance data. The submission should also include comparisons with one or more predicate devices.
⦿ Identification of Predicate Device(s):
Identify one or more legally marketed devices (predicate devices) to which the new device will be compared. Substantial equivalence is a key concept in the 510(k) process, and demonstrating it is crucial for obtaining clearance.
⦿ 510(k) Submission to the FDA:
Submit the 510(k) application to the FDA. The submission includes all relevant information and data supporting the claim of substantial equivalence. The FDA reviews the submission to determine if the new device is substantially equivalent to the predicate device(s).
⦿ FDA Review Process:
The FDA reviews the 510(k) submission to assess whether the new device is substantially equivalent in terms of intended use, technological characteristics, and performance to the predicate device(s). The review may involve multiple stages of communication between the FDA and the submitter.
⦿ FDA Decision:
Based on the review, the FDA makes one of the following decisions:
Following its review, the FDA generally issues one of two substantial equivalence determinations:
⦿ Substantially Equivalent (SE): FDA determines that the device meets the applicable substantial equivalence criteria. The manufacturer receives 510(k) clearance, allowing the device to be commercially marketed in the United States, subject to other applicable regulatory requirements.
⦿ Not Substantially Equivalent (NSE): FDA determines that the device does not meet the substantial equivalence criteria. The manufacturer cannot market the device based on that 510(k) and must evaluate the appropriate next regulatory steps, which may include a De Novo request or another applicable pathway.
The flowchart below illustrates the key decision points involved in FDA’s substantial equivalence assessment.
⦿ Post-Market Requirements:
Once the device is on the market, the manufacturer is required to comply with post-market surveillance and reporting requirements. This includes monitoring and reporting adverse events, product recalls, and other safety-related issues.
It’s important to note that the 510(k) process is specific to certain types of medical devices and is not applicable to all devices. Devices with higher risk profiles may require more rigorous regulatory pathways, such as the Premarket Approval (PMA) process. The decision-making process involves close collaboration between the device manufacturer and the FDA to ensure the safety and effectiveness of medical devices available to the public.
For more information on how to navigate through the flow chart, please feel free to contact us at [email protected]
Read about our recent blog on “13 mistakes to avoid in the 510 K Submission” below:
510(k) Flowchart Path
FAQs
-
What does the FDA 510(k) flowchart show me?
It visually outlines the step-by-step decision process the FDA uses to understand if a device is an appropriate 510(k) candidate.
-
How do I know which path my device takes in the 510(k) flowchart?
The path helps understand whether the device has a higher probability of having substantial equivalence or otherwise.
-
What are key decision-points (ex: predicate device, substantial equivalence) in the flowchart?
Major decision points include determining substantial equivalence vs. NSE.
-
What timelines and review stages correspond to the flows in the 510(k) chart?
The objective of the FDA is to come up with a decision on substantial equivalence within 90 days. This process involves acceptance, substantive review, and a decision stage. Time on hold is not counted in the FDA day, so the actual time to clearance might be more. This review process is distinct from the process of substantial equivalence chart.
-
What are the common mistakes at each flowchart branch and how to avoid them?
Typical errors include incorrect predicate choice, inadequate equivalence data, incorrect interpretation of intended use and missing test reports—avoid by thorough gap analysis and documentation.
